PDE11A Assay Kit

Phosphodiesterases (PDEs) are involved in the dynamic regulation of cAMP and cGMP signaling. PDE11A has been observed in skeletal muscle, prostate, testis, salivary gland, thyroid gland, and liver. PDE11A may play role in the CNS with an association to major depressive disorder. The PDE11A Assay Kit is designed for identification of PDE11A inhibitors using fluorescence polarization. The assay is based on the binding of a fluorescent nucleotide monophosphate generated by PDE11A to the binding agent. The PDE11A inhibitor screening assay kit comes in a convenient 96-well format, including purified PDE11A enzyme, fluorescently labeled PDE11A substrate (cAMP), binding agent, and PDE assay buffer for 100 enzyme reactions. The key to the PDE11A Assay Kit is the specific binding agent. Using this kit, only two simple steps on a microtiter plate are required for PDE11A reactions. First, the fluorescently labeled cAMP is incubated with a sample containing PDE11A for 1 hour. Second, a binding agent is added to the reaction mix to produce a change in fluorescent polarization that can then be measured using a fluorescence reader.